Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells
US8551485B2 · kind B2 · utility
20Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2009 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Sep 6, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes humanized antibodies that target CD40, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an FcγR or alters effector function as compared to the parent antibody. Also disclosed are methods of using the antibodies of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.